{"id":"https://openalex.org/W2199948760","doi":"https://doi.org/10.1158/1538-8514.pi3k14-b42","title":"Abstract B42: Targeting PI3K in personalized treatment of BRAF-mutated pediatric low-grade gliomas","display_name":"Abstract B42: Targeting PI3K in personalized treatment of BRAF-mutated pediatric low-grade gliomas","publication_year":2015,"publication_date":"2015-07-01","ids":{"openalex":"https://openalex.org/W2199948760","doi":"https://doi.org/10.1158/1538-8514.pi3k14-b42","mag":"2199948760"},"language":"en","primary_location":{"id":"doi:10.1158/1538-8514.pi3k14-b42","doi":"https://doi.org/10.1158/1538-8514.pi3k14-b42","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-8514.pi3k14-b42","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://escholarship.org/content/qt5kz3j3gs/qt5kz3j3gs.pdf?t=p4wpzy","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001519803","display_name":"Aleksandra Olow","orcid":"https://orcid.org/0000-0002-0113-8306","observed_orcids":["https://orcid.org/0000-0002-0113-8306"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleksandra K. Olow","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108627145","display_name":"Sabine Mueller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabine Mueller","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xiaodong Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaodong Yang","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037070644","display_name":"Rintaro Hashizume","orcid":"https://orcid.org/0000-0002-9373-7831","observed_orcids":["https://orcid.org/0000-0002-9373-7831"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rintaro Hashizume","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073603294","display_name":"William A. Weiss","orcid":"https://orcid.org/0000-0003-2230-9132","observed_orcids":["https://orcid.org/0000-0003-2230-9132"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Weiss","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086085263","display_name":"Adam Cain Resnick","orcid":"https://orcid.org/0000-0003-0436-4189","observed_orcids":["https://orcid.org/0000-0003-0436-4189"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam C. Resnick","raw_affiliation_strings":["2The Children's Hospital of Philadelphia, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The Children's Hospital of Philadelphia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108516428","display_name":"Angela Jae Sievert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela J. Sievert","raw_affiliation_strings":["2The Children's Hospital of Philadelphia, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The Children's Hospital of Philadelphia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006262715","display_name":"Mitchel Stuart Berger","orcid":"https://orcid.org/0000-0003-1983-4892","observed_orcids":["https://orcid.org/0000-0003-1983-4892"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitchel S. Berger","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085910888","display_name":"Nalin M. Gupta","orcid":"https://orcid.org/0000-0001-9539-7052","observed_orcids":["https://orcid.org/0000-0001-9539-7052"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nalin Gupta","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David C. James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David C. James","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085032736","display_name":"Daphne Adele Haas-Kogan","orcid":"https://orcid.org/0000-0002-2378-4800","observed_orcids":["https://orcid.org/0000-0002-2378-4800"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daphne A. Haas-Kogan","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"7_Supplement","first_page":"B42","last_page":"B42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-low-grade-glioma","display_name":"pediatric low-grade glioma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.824999988079071},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8059999942779541},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.6990000009536743},{"id":"https://openalex.org/keywords/plx4720","display_name":"PLX4720","score":0.8730000257492065},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.8700000047683716},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.925000011920929},{"id":"https://openalex.org/keywords/kiaa1549-braf-fusion","display_name":"KIAA1549-BRAF fusion","score":0.878000020980835},{"id":"https://openalex.org/keywords/pilocytic-astrocytoma","display_name":"pilocytic astrocytoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5659999847412109},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5989999771118164},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.760706901550293},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7123529314994812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6623363494873047},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6177222728729248},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.6028374433517456},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.4967268109321594},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.475088506937027},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42926278710365295},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4104980230331421},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.40271252393722534},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30706292390823364},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3019171357154846},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29964208602905273},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.29557114839553833},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1326693296432495}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1538-8514.pi3k14-b42","doi":"https://doi.org/10.1158/1538-8514.pi3k14-b42","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-8514.pi3k14-b42","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt5kz3j3gs","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/5kz3j3gs","pdf_url":"https://escholarship.org/content/qt5kz3j3gs/qt5kz3j3gs.pdf?t=p4wpzy","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, vol 14, iss 7_Supplement","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:escholarship.org:ark:/13030/qt5kz3j3gs","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/5kz3j3gs","pdf_url":"https://escholarship.org/content/qt5kz3j3gs/qt5kz3j3gs.pdf?t=p4wpzy","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, vol 14, iss 7_Supplement","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2199948760.pdf","grobid_xml":"https://content.openalex.org/works/W2199948760.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6987546664","https://openalex.org/W2159517181","https://openalex.org/W2403601567","https://openalex.org/W4365133679","https://openalex.org/W2602580724","https://openalex.org/W2326161279","https://openalex.org/W7127886184","https://openalex.org/W2007679040","https://openalex.org/W4406130256","https://openalex.org/W4380362753"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Pediatric":[2],"low-grade":[3,482],"gliomas":[4,152],"(PLGG)":[5],"constitute":[6],"the":[7,56,68,121,137,165,278,350,356,393,488,493],"most":[8,77],"common":[9],"group":[10],"of":[11,59,109,124,148,158,173,179,187,199,232,272,289,365,379,408,419,479,487],"central":[12],"nervous":[13],"system":[14],"tumors":[15],"in":[16,86,118,146,156,171,194,277,349,360,476,496],"children.":[17],"Although":[18],"they":[19],"exhibit":[20],"rare":[21],"malignant":[22],"transformation":[23],"and":[24,61,105,114,193,201,204,229,236,248,254,291,301,335,387,392],"relatively":[25],"slow":[26],"growth,":[27],"PLGGs":[28,60,119,421],"pose":[29],"great":[30],"morbidity.":[31],"Viewed":[32],"as":[33,190,426],"a":[34,87,134],"chronic":[35],"disease,":[36],"ideal":[37],"therapy":[38,200],"for":[39,72],"PLGG":[40,280,351],"should":[41],"carry":[42],"limited":[43],"side":[44],"effects":[45,296,338],"that":[46,65,126,177,339],"can":[47,184],"be":[48,399],"best":[49],"achieved":[50],"through":[51],"selective,":[52],"personalized":[53,73,477],"therapy.":[54],"Despite":[55],"known":[57],"heterogeneity":[58],"characterized":[62],"driver":[63],"mutations":[64],"together":[66],"offer":[67],"perfect,":[69],"timely":[70],"platform":[71],"approaches":[74],"to":[75,163,196,207,315,389,413,439],"therapy,":[76],"children":[78],"are":[79],"still":[80,423],"treated":[81,362],"with":[82,363,370],"standard":[83],"chemotherapy":[84],"protocols":[85],"\u201cone":[88],"treatment":[89,418,478],"fits":[90],"all\u201d":[91],"approach.":[92],"Recent":[93],"genomic":[94],"studies":[95],"have":[96],"defined":[97],"recurrent,":[98],"diverse":[99],"alterations":[100],"driving":[101],"WHO":[102],"grade":[103,149],"1":[104],"2":[106],"PLGGs.":[107,174],"Activation":[108],"mitogen":[110],"protein":[111],"kinase":[112,116,135],"(MAPK)":[113],"phosphatidylinositol-3\u2032":[115],"(PI3K)":[117],"suggests":[120],"potential":[122],"efficacy":[123,198],"agents":[125,192],"target":[127],"these":[128,273,396],"key":[129],"growth":[130],"regulatory":[131],"pathways.":[132],"BRAF,":[133],"within":[136],"MAPK":[138],"pathway,":[139],"is":[140,169,384,411,422,431],"activated":[141,170],"by":[142,343,401],"missense":[143],"mutation":[144],"(V600E)":[145],"\u223c20%":[147],"2-4":[150],"pediatric":[151,481],"or":[153,222,367,381],"KIAA1549-BRAF":[154],"fusion":[155,328],"\u223c60%":[157],"pilocytic":[159],"astrocytomas.":[160],"In":[161,269,285,308,326,346],"addition":[162],"RAS/MEK/MAPK/ERK,":[164],"PI3K/AKT/mTOR":[166],"signaling":[167],"cascade":[168],"\u223chalf":[172],"We":[175,211],"hypothesize":[176],"knowledge":[178],"individual":[180],"tumor":[181],"BRAF":[182,224],"genotype":[183],"guide":[185],"selection":[186],"PI3K/MAPK":[188],"inhibitors":[189,242,274,383],"single":[191,306,390,414,427],"combinations,":[195],"maximize":[197],"overcome":[202],"innate":[203],"acquired":[205],"resistance":[206],"targeted":[208],"agents.":[209,307],"Methods:":[210],"used":[212],"human":[213],"glioma":[214],"cell":[215,298,302,333],"lines":[216],"containing":[217],"BRAFV600E":[218,286,376],"(AM38,":[219],"DBT-RG,":[220],"BT40),":[221],"wild-type":[223],"(BRAFWT;":[225],"SF188,":[226],"SF9427,":[227],"SF9402)":[228],"isogenic":[230,323],"systems":[231],"KIAA1549:BRAF-expressing":[233,420],"NIH3T3":[234],"cells":[235],"BRAFV600E-expressing":[237],"murine":[238,324],"brain":[239],"tumors.":[240],"Signaling":[241],"included":[243],"everolimus":[244],"(mTOR),":[245],"PLX4720":[246],"(BRAFV600E),":[247],"AZD6244":[249],"(MEK).":[250],"Cell":[251],"cycle":[252,303],"distribution":[253],"apoptosis":[255],"were":[256,320,340],"assessed":[257,276],"using":[258,264,322],"flow":[259],"cytometry;":[260],"proliferation":[261],"was":[262,275,312],"determined":[263],"an":[265],"ATP-based":[266],"assay":[267],"(CellTiter-Glo).":[268],"vivo":[270,347],"activity":[271],"BT40":[279,354],"xenograft":[281,352],"mouse":[282],"model.":[283],"Results:":[284],"cells,":[287,310,329],"combination":[288,364,378,407],"PLX4720+everolimus":[290],"PLX4720+AZD6244":[292],"exhibited":[293],"significantly":[294],"greater":[295,440],"on":[297],"viability,":[299],"apoptosis,":[300],"than":[304],"respective":[305,316,371],"BRAFWT":[309,405],"everolimus+AZD6244":[311],"superior":[313,388,412],"compared":[314,369],"monotherapies.":[317],"Similar":[318],"results":[319],"found":[321],"cells.":[325],"KIAA1549:BRAF":[327],"MEK":[330,429],"inhibition":[331,430,436],"reduced":[332],"viability":[334],"S-phase":[336],"content,":[337],"modestly":[341],"augmented":[342],"mTOR":[344,435],"inhibition.":[345],"experiments":[348],"model":[353],"showed":[355],"greatest":[357],"survival":[358],"advantage":[359],"mice":[361],"AZD6244+PLX4720":[366],"AZD6244+everolimus":[368],"monotherapies":[372],"(p<0.01).":[373],"Conclusions:":[374],"For":[375,404],"tumors,":[377],"everolimus+MEK":[380,409],"PLX4720+MEK":[382],"equally":[385],"efficacious":[386,433],"agents,":[391],"choice":[394],"between":[395],"two":[397],"might":[398],"dictated":[400],"clinical":[402],"tolerability.":[403],"PLGGs,":[406],"inhibitor":[410],"agent":[415,428],"therapies.":[416],"Optimal":[417],"under":[424],"investigation":[425],"extremely":[432],"but":[434],"may":[437],"contribute":[438],"overall":[441],"anti-neoplastic":[442],"effects.":[443],"Citation":[444],"Format:":[445],"Aleksandra":[446],"K.":[447],"Olow,":[448],"Sabine":[449],"Mueller,":[450],"Xiaodong":[451],"Yang,":[452],"Rintaro":[453],"Hashizume,":[454],"William":[455],"Weiss,":[456],"Adam":[457],"C.":[458,469],"Resnick,":[459],"Angela":[460],"J.":[461],"Sievert,":[462],"Mitchel":[463],"S.":[464],"Berger,":[465],"Nalin":[466],"Gupta,":[467],"David":[468],"James,":[470],"Daphne":[471],"A.":[472],"Haas-Kogan.":[473],"Targeting":[474,492],"PI3K":[475],"BRAF-mutated":[480],"gliomas.":[483],"[abstract].":[484],"In:":[485],"Proceedings":[486],"AACR":[489],"Special":[490],"Conference:":[491],"PI3K-mTOR":[494],"Network":[495],"Cancer;":[497],"Sep":[498],"14-17,":[499],"2014;":[500],"Philadelphia,":[501],"PA.":[502],"Philadelphia":[503],"(PA):":[504],"AACR;":[505],"Mol":[506],"Cancer":[507],"Ther":[508],"2015;14(7":[509],"Suppl):Abstract":[510],"nr":[511],"B42.":[512]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}